Treatment with BM-MSCs expressing telomerase led to a significant reduction in skin hypodermal thickness in SSc mice. Reintroduction of telomerase activity through TERT transfection restored the immunomodulatory functions of TERT−/− BM-MSCs. Here, TERT is linked to systemic sclerosis.